Compare Cytokinetics Inc (CYTK) vs United States Oil ETF (USO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs United States Oil ETF — how do they compare? Cytokinetics Inc trades at $62.91 (market cap $8.62B), while United States Oil ETF trades at $148.2 (market cap $1.90B). The key difference: Cytokinetics Inc is far larger — about 4.5× United States Oil ETF's market cap, and United States Oil ETF is trading nearer its 52-week high, Cytokinetics Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Cytokinetics Inc for 19 Days and United States Oil ETF for 21 Days on average.
| CYTK | USO | |
|---|---|---|
Market Cap | $8.62B | $1.90B |
Volume | 2,594,626 | 5,932,922 |
Sector | Health | — |
52-Week High | $87.26 | $161.86 |
52-Week Low | $54.76 | $66.17 |
Typical Hold Time | 19 Days | 21 Days |
Enterprise Value | $8.72B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CYTK trades at $62.01, up 1.46% on the day, with a bearish technical signal from moving averages but oversold RSI readings. The company reported Q2 2026 EPS of -$1.50, beating expectations, but maintains deeply negative profitability with a net income margin of -1,321.12% for 2026. Recent news highlights clinical progress for aficamten in hypertrophic cardiomyopathy studies and presentations at major medical conferences.
Wall Street sentiment is overwhelmingly bullish with a 97.14% buy rating and a $112.60 consensus price target, signaling strong upside potential. However, high cash burn, substantial losses, and significant debt-to-asset ratio of 81.23% present substantial financial risks. Investment appeal hinges on successful commercialization of its pipeline amid intense competition.
USO is trading at $147.58, up 2.55% with a bullish technical signal supported by moving averages. Recent news highlights Middle East tensions affecting oil supply, with OPEC+ maintaining output targets and G-7 planning strategic oil releases. The stock shows strength above key support levels amid volatile energy market conditions.
The outlook remains cautiously optimistic given geopolitical risks and supply constraints. Investment opportunities include potential price appreciation from supply disruptions, while risks involve oil price volatility and regulatory pressures from climate litigation. Institutional sentiment appears mixed with neutral oscillators suggesting near-term consolidation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About United States Oil ETF
This ETF invests primarily in futures contracts for light, sweet crude oil, other types of crude oil, diesel-heating oil, gasoline, natural gas, and other petroleum-based fuels.
Read more on USO →
